Toy Pearl, Popovsky Mark A, Abraham Edward, Ambruso Daniel R, Holness Leslie G, Kopko Patricia M, McFarland Janice G, Nathens Avery B, Silliman Christopher C, Stroncek David
School of Medicine, University of California-San Francisco, San Francisco, CA 94143-0100, USA.
Crit Care Med. 2005 Apr;33(4):721-6. doi: 10.1097/01.ccm.0000159849.94750.51.
Transfusion-related acute lung injury (TRALI) is now the leading cause of transfusion-associated mortality, even though it is probably still underdiagnosed and underreported.
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE ACTION: The National Heart, Lung, and Blood Institute convened a working group to identify areas of research needed in TRALI. The working group identified the immediate need for a common definition and thus developed the clinical definition in this report.
The major concept is that TRALI is defined as new acute lung injury occurring during or within 6 hrs after a transfusion, with a clear temporal relationship to the transfusion. Also, another important concept is that acute lung injury temporally associated with multiple transfusions can be TRALI, because each unit of blood or blood component can carry one or more of the possible causative agents: antileukocyte antibody, biologically active substances, and other yet unidentified agents.
Using the definition in this report, clinicians can diagnose and report TRALI cases to the blood bank; importantly, researchers can use this definition to determine incidence, pathophysiology, and strategies to prevent this leading cause of transfusion-associated mortality.
输血相关急性肺损伤(TRALI)现已成为输血相关死亡的主要原因,尽管其可能仍存在诊断不足和报告不足的情况。
美国国立心肺血液研究所召集了一个工作组,以确定TRALI所需的研究领域。该工作组确定了对通用定义的迫切需求,并因此制定了本报告中的临床定义。
主要概念是,TRALI被定义为在输血期间或输血后6小时内发生的新的急性肺损伤,与输血有明确的时间关系。此外,另一个重要概念是,与多次输血在时间上相关的急性肺损伤可能是TRALI,因为每单位血液或血液成分都可能携带一种或多种可能的致病因素:抗白细胞抗体、生物活性物质以及其他尚未确定的因素。
使用本报告中的定义,临床医生可以诊断TRALI病例并向血库报告;重要的是,研究人员可以使用此定义来确定发病率、病理生理学以及预防这种输血相关死亡主要原因的策略。